این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
پنجشنبه 20 آذر 1404
Iranian Journal of Medical Physics
، جلد ۲۲، شماره ۳، صفحات ۲۰۳-۲۰۸
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Human Absorbed Dose Estimation of 89Zr-Anti-HER2 Complex Based on Animal Data
چکیده انگلیسی مقاله
Introduction: This study aimed to estimate the radiation absorbed dose of human organs after injection of a high-potential PET radioimmunoconjugate of HER2+ breast cancers using the medical internal radiation dose (MIRD) method and the radiation dose assessment resource (RADAR) formalism. Material and Methods: 89Zr was produced by the nuclear reaction of 89Y with protons (p,n), and purified by a column filled with ZR resin. The radionuclide, chemical, and radiochemical purities of the 89Zr solution were measured using gamma spectrometry, inductively coupled plasma (ICP), and radio-thin-layer chromatography (RTLC) methods, respectively. The conjugated anti-HER2 with deferoxamine (DFO) was labeled with an in-house produced 89Zr at the optimized condition to prepare 89Zr-Anti-HER2, and its radiochemical purity was assessed by the RTLC method. The stability of the radioimmunoconjugate was assessed in Phosphate-buffered saline (PBS) buffer and human serum at various intervals. Biodistribution of the final complex was studied in tumor-bearing mice at specified intervals. Finally, the absorbed dose of human organs was estimated using the MIRD method and RADAR formalism based on animal data. Results: 89Zr radionuclide was produced by the radiochemical and radionuclide purities of >99%, and >99.99%, respectively, while the chemical impurities were < 0.1 ppm. The radiolabeled antibody was prepared with radiochemical purity >98% at optimized conditions. The results showed the liver received the maximum amount of the absorbed dose of 1.49 mGy/MBq, and other organs received < 0.87 mGy/MBq. Conclusion: 89Zr-Anti-HER2 complex is a promising agent for PET imaging of patients with HER2+ tumors with high safety in the country.
کلیدواژههای انگلیسی مقاله
Zirconium, 89 Positron, Emission Tomography Breast Neoplasms Radiation
نویسندگان مقاله
| Hassan Yousefnia
Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), Tehran, 14155-1339, Iran.
| samaneh zolghadri
Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), Tehran, 14155-1339, Iran.
| Arezou Karimian
Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), Tehran, 14155-1339, Iran.
نشانی اینترنتی
https://ijmp.mums.ac.ir/article_26758.html
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
Original Paper
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات